Director Of Operations
CurrentAs the Director of Operations at Sonic Incytes, I work closely with an incredibly talented team to drive innovation and continuous improvement across a multifaceted portfolio of departments including: human resources, inventory and logistics, sales and marketing and corporate administration/strategy. Recognizing the rise of fatty liver disease, Sonic Incytes has made it our mission to make liver health a new vital sign. Our product VELACUR is an AI guided 3D S-WAVE ultrasound elastography device that measures liver stiffness and attenuation, the two key indicators of fatty liver disease. As rates of fatty liver disease rise and with new treatments for MASLD and MASH becoming available, the need for a high-quality, non-invasive, point of care imaging tool is greater than ever. VELACUR offers superior economics, easy to use pre-installed software and comprehensive training, making implementing our ultrasound elastography device an easy choice for your practice.